Let’s hit the highlights, quoting directly from the review paper by Kory et al, Jan 2021:

Kory and Marik compiled eight studies (three randomized controlled studies and five observational controlled studies) demonstrating efficacy in the prevention of COVID-19 with significantly decreased transmission.

They found 19 controlled studies that showed significant impacts on time to recovery, hospital stay, decrease in viral loads, reductions in the duration of cough and decreased mortality.

In medical history pre-COVID, this body of research about ivermectin would be applauded for bringing value in the midst of a pandemic. In the medical era pre-COVID, the judgment and experience of clinicians at the patient’s bedside counted for something.

Pre-COVID, we taught medical students to use keen observational skills and keep accurate records of whether the patient improved or deteriorated after the treatment strategies used.

In the Age of COVID, pharmacists who chide doctors that “COVID does not have an exoskeleton” deny patients ivermectin — a safe, cheap, effective, and potentially life-saving early treatment.

Ivermectin

If you or your patients are having trouble getting ivermectin prescriptions filled for COVID 19 prevention or treatment, see this excellent resource from the Front Line COVID 19 Critical Care Alliance.